內險股集體大漲 中國太保(2601.HK)漲超5%領漲
格隆匯11月3日丨港A市場保險股齊漲,港股市場的內險股漲勢更為明顯。其中,中國太保漲超5%領漲,中國人壽、新華保險和中國太平漲超4%,中國財險、中國人民保險漲超2%,眾安在線和中國平安漲超1%。機構普遍認為進入四季度,保險股業績、估值有望迎來“雙修復”。天風證券表示,在市場對第二年經濟預期不悲觀的情況下,每年四季度容易出現估值切換行情,利好保險股。保險公司配置的股票多為低估值標的,市場風格切換有望刺激保險股開啟“戴維斯雙擊”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.